Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jacob Babu

Orthopaedic Surgery Libertyville, IL Medical Doctor

NPI 1861804841 CMS profile 1042762

724 Florsheim Dr, Libertyville, IL 60048

Open in the dashboard

General payments

$27,101

174 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jacob Babu of Libertyville, IL is reported in the CMS Open Payments database as having received $27,101 across 174 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $407 11
2024 General $4,190 16
2023 General $8,573 48
2022 General $3,776 18
2021 General $5,976 45
2020 General $845 11
2019 General $3,334 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacob Babu
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jacob Babu were reported at $407. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Jacob Babu Orthopaedic Surgery median Middle half National median
2019 $3,334 $644 $140–$2,844 $163
2020 $845 $312 $75–$1,860 $114
2021 $5,976 $520 $117–$2,495 $132
2022 $3,776 $598 $128–$2,731 $149
2023 $8,573 $461 $128–$2,264 $160
2024 $4,190 $497 $134–$2,475 $164
2025 $407 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $10,398 23 payments
  2. Stryker Corporation $3,522 38 payments
  3. Globus Medical, Inc. $3,197 22 payments
  4. Cerapedics, Inc. $1,822 4 payments
  5. Medical Device Business Services, Inc. $1,221 7 payments
  6. Abbott Laboratories $1,151 7 payments
  7. elliquence, LLC $1,000 1 payment
  8. Medtronic, Inc. $806 9 payments
  9. Arthrex, Inc. $601 9 payments
  10. DePuy Synthes Sales Inc. $510 10 payments
  11. Other $2,872 44 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $15,907 34 payments
  2. Food and Beverage $8,374 136 payments
  3. Honoraria $2,500 2 payments
  4. Education $320 2 payments
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $9,764 11 payments
  2. i-FACTOR Putty $1,822 4 payments
  3. RISE-L $1,286 6 payments
  4. Teligen $1,236 12 payments
  5. ES2 SPINAL SYSTEM $1,148 6 payments
  6. PROCLAIM $1,129 6 payments
  7. EXCELSIUS GPS $813 3 payments
  8. RISE $652 4 payments
  9. EVEREST SPINAL SYSTEM $491 8 payments
  10. TRITANIUM $367 5 payments
  11. Other $6,453 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

778

Median for Orthopedic Surgery: 203

Drug cost

$5,229

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 249 $2,349
Meloxicam Generic 256 $1,030
Methylprednisolone Generic 124 $773
Diclofenac Sodium Generic 28 $482
Cyclobenzaprine Hcl Generic 41 $224
Tizanidine Hcl Generic 27 $186
Oxycodone Hcl Generic 16 $94
Tramadol Hcl Generic 37 $91

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 114 billing codes

Paid by Medicare

$308,884

Of which drugs: $640

Medicare patients

705

Average age 75

Services billed

5,635

418 women, 287 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 29%
Diabetes 28%
Osteoporosis 27%
Chronic kidney disease 22%
Depression 22%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 83 504 $395
Injection, gadoterate meglumine, 0.1 ml A9575 Office 11 1,760 $166
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 57 680 $60
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 116 186 $19

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

174 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record